But the mechanisms remain unclear in PAAD, especially the regulatory network of GLUT1 and competitive endogenous RNAs (ceRNAs), as well as the relationship between GLUT1 and malignant biological behaviors of PAAD. The gene discussed is SLC2A1; the disease is pancreatic adenocarcinoma.